Fundz

Who to call at BioLineRx Ltd, and when

Fundz watches for the moments BioLineRx Ltd starts buying, and tells you who to reach.

  • An alert the day BioLineRx Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BioLineRx Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BioLineRx Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

BioLineRx Enters into $5.6 Million Agreement for Royalty Monetization with Soleus Capital to Fund GLIX1 Development.

Nov 18, 2026

Contract Type

agreement

Tel AvivBiotechnologyHealthcareHealth CareTherapeuticsBiopharmaresearch

Description

BioLineRx has entered into an agreement with Soleus Capital for the sale of its future royalty payments from APHEXDA for a one-time payment of $5.6 million. The funds will support the ongoing Phase 1/2a clinical trial of GLIX1, while the company retains rights to future milestone payments.

Quick answer

BioLineRx Enters into $5.6 Million Agreement for Royalty Monetization with Soleus Capital to Fund GLIX1 Development. (November 18, 2026). BioLineRx Ltd is based in Tel Aviv, Tel Aviv District, Israel.

What agreement did BioLineRx Ltd announce on November 18, 2026?
BioLineRx has entered into an agreement with Soleus Capital for the sale of its future royalty payments from APHEXDA for a one-time payment of $5.6 million. The funds will support the ongoing Phase 1/2a clinical trial of GLIX1, while the company retains rights to future milestone payments.
What does BioLineRx Ltd do?
BioLineRx is a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases.
Where is BioLineRx Ltd based?
BioLineRx Ltd is based in Tel Aviv, Tel Aviv District, Israel.
Which similar companies announced agreements around the same time?
AbbVie Inc. (November 3, 2026), Aarvik Therapeutics (November 3, 2026), AstraZeneca Pharma India (November 17, 2026) and Kernal Biologics (November 17, 2026) also announced agreements within 45 days of BioLineRx Ltd.

Source: Fundz verified event record.

Other recent agreements in Healthcare and Therapeutics

Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.

Company Information

Company

BioLineRx Ltd

Location

2 HaMa'ayan Street

Tel Aviv, Tel Aviv District, Israel

About

BioLineRx is a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases. The company's first approved product is APHEXDA® (motixafortide) with an indication in the U.S. for stem cell mobilization for autologous transplantation in multiple myeloma. BioLineRx is advancing a pipeline of investigational medicines for patients with sickle cell disease, pancreatic cancer, and other solid tumors. Headquartered in Israel, and with operations in the U.S., the company is driving innovative therapeutics with end-to-end expertise in development and commercialization, ensuring life-changing discoveries move beyond the bench to the bedside.

Related People

Phil
Senior decision-maker at this company
••••••••@••••••••

See Phil's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for BioLineRx Ltd's next move

Learn about Strategic plan

BioLineRx Ltd signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.